As technology advances, media applications continue to transform education and engagement. Healthcare stakeholders can access a myriad of multi-dimensional learning opportunities that improve the retention of complex information.
As visual learners, healthcare professionals are especially attracted to #immersivemultimedia bundled with extended reality applications, available at conferences, in the office, or at home on a computer or mobile device.
At @ConfideoLabs, we are focused on identifying new ways to help pharmaceutical marketers create experiences that connect with customers in new and innovative ways. Many of our clients have turned to #augmentedreality, which overlays digitally created content (animations, holograms, video, etc) into a viewer’s real-world environment to optimize storytelling.
In recent years, we have pioneered the inclusion of #volumetricvideo capture to enable holographic deployments of physicians that bolster marketing efforts and redefine clinical storytelling by bringing Key Opinion leaders into the room with their colleagues in full 3D.
Scroll through for a peak at some recent deployments, and get in touch to learn more -|- [email protected]@mattrirwin@MikeMarett
Dr Philipp Sewerin presents findings from German ArthroMark cohort where baseline MRI RAMRIS score predicted EULAR response in RA https://t.co/v5ZLRLd37I @philippsewerin@AWIRGROUP
What a difference angle makes! Important to consider when looking at x-rays! Presented by Dr Philipp Sewerin at AWIR San Diego summit @AWIRGROUP@philippsewerin
First human MRI 1977 using 0.05T progressed to clarity in modern images within 1-2 generations presented by Dr Philipp Sewerin at AWIR San Diego summit. @philippsewerin@AWIRGROUP
Sad to see Olumiant's attempt to be an effective therapy for lupus come to an end based on weak efficacy data, no new safety signals. Potential indication for atopic dermatitis also appears doubtful. #Olumiant#SLE#lupus https://t.co/WFWlN0yevu
Congratulations to patients with ankylosing spondylitis #AS who now have another therapeutic option with #Xeljanz. Proud to partner with @Pfizer in helping manage this disease!